MASHINIi

Elicio Therapeutics, Inc..

ELTX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and other diseases. The company's Amphiphile technology platform is designed to directly deliver immunogens and other therapeutic agents to the lymph nodes, which are critical for ini...Show More

Ethical Profile

Mixed.

Elicio Therapeutics (ELTX.US) shows a mixed ethical profile. Its primary focus on developing cancer immunotherapies, such as ELI-002 for KRAS mutations, directly contributes to better health outcomes. However, the company's clinical-stage biotechnology operations are fundamentally linked to animal testing during preclinical drug development, a standard industry practice. Critics point to an absence of explicit cruelty-free certifications. For other areas like fair pay, ethical sourcing, and environmental impact, there is insufficient public information to detail specific practices or controversies.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-20
-100100
Kind to Animals-40
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Elicio Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Elicio Therapeutics, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess Elicio Therapeutics, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Elicio Therapeutics, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-20

Elicio Therapeutics has a formal whistleblower protection policy in place, which includes procedures for receiving, retaining, and treating complaints regarding accounting, internal controls, or auditing matters.

1
The company provides an ethics hotline and an anonymous reporting app for suspected violations.
2
The Audit Committee, whose members must be independent, is responsible for investigating ethics helpline reports.
3
The company also has a Code of Business Conduct and Ethics, adopted in January 2021 and amended in February 2024 and March 2025, which outlines ethical standards for all personnel, emphasizing compliance with applicable laws and regulations, including government relations.
4
This code also addresses conflicts of interest, fair dealing, and accuracy of financial reports.
5
The company has not had any financial restatements in the provided articles, only minor disclosure tweaks.

Kind to Animals

-40

Elicio Therapeutics heavily relies on in vivo testing in mice, including murine syngeneic tumor models, to evaluate immune responses and anti-tumor activity.

1
While in vitro assays are also used, the company's research primarily involves small animal experiments, including handling, injections, and organ collections.
2
All animal studies are conducted following IACUC-approved protocols and adhere to local, state, and federal guidelines, as well as committee-approved animal protocols from institutions like MIT and CHOP.
3

No War, No Weapons

0

The provided articles, including company press releases, corporate governance documents, and sustainability data summaries, explicitly state that no data relevant to 'No War, No Weapons' metrics is present or available for Elicio Therapeutics, Inc.

1
The company's core business is described as clinical-stage biotechnology focused on immunotherapies for cancer.
2
However, without specific evidence detailing the absence of involvement in arms, defense, or related activities, no KPIs can be scored based on the provided information.

Planet-Friendly Business

0

The provided articles for Elicio Therapeutics, Inc. (ELTX.US) primarily detail financial performance, clinical trial updates, and corporate governance. No specific, quantifiable data or information related to environmental stewardship, carbon emissions, renewable energy use, water management, waste diversion, climate targets, or other planet-friendly business practices for ELTX.US was found. Information regarding Elicio NV's environmental initiatives is explicitly stated as not applicable to ELTX.US.

1

Respect for Cultures & Communities

0

No specific, quantitative evidence regarding Elicio Therapeutics, Inc.'s performance on any of the 'Respect for Cultures & Communities' KPIs was found in the provided articles.

1
All articles explicitly state that no relevant data was available for the company concerning these metrics.

Safe & Smart Tech

0

No evidence available to assess Elicio Therapeutics, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, quantitative data regarding Elicio Therapeutics, Inc.'s waste management practices, product recyclability, packaging sustainability, or other zero waste and sustainable product initiatives is available in the provided articles.

1
One article explicitly states that sustainability data for ELTX is currently not available.
2

Own Elicio Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.